Friday, 16 October 2026European Markets

CM.COM Stock Jumps By 22% In The Last 10 Sessions

Loading stream...

(VIANEWS) - Shares of CM.COM (AEX-Index: CMCOM.AS) jumped by a staggering 22.65% in 10 sessions from €7.99 to €9.80 at 05:08 EST on Monday, after three successive sessions in a row of gains. AEX-Index is sliding 0.21% to €759.32, after five sequential sessions in a row of losses.

CM.COM's last close was €9.80, 38.52% below its 52-week high of €15.94.

About CM.COM

CM.com N.V. provides cloud software for conversational commerce worldwide. It operates in four segments: Communication Platform as a Service (CPaaS), Software as a Service (SaaS), Payment Services, and Ticketing. Its products include Mobile Service Cloud, an all-in-one customer service software; Conversational AI Cloud for automating customer service with AI powered chats and voice bots; Mobile Marketing Cloud, an omnichannel customer engagement solution for businesses; Ticketing that offers event, seated, and attraction ticketing services; Sign, which allows the user to complete contracts, agreements, and documents without printing and scanning; communications platform for mobile messaging and voice for business communication; and payments platform that accepts online and POS payments. CM.com N.V. was founded in 1999 and is headquartered in Breda, the Netherlands.

Earnings Per Share

As for profitability, CM.COM has a trailing twelve months EPS of €-1.53.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is negative -59.1%.

Volatility

CM.COM's last week, last month's, and last quarter's current intraday variation average was 1.90%, 0.81%, and 1.96%.

CM.COM's highest amplitude of average volatility was 2.40% (last week), 1.92% (last month), and 1.96% (last quarter).

Yearly Top and Bottom Value

CM.COM's stock is valued at €9.80 at 05:08 EST, way under its 52-week high of €15.94 and way higher than its 52-week low of €7.71.

Volume

Today's last reported volume for CM.COM is 189200 which is 149.6% above its average volume of 56250.

More news about CM.COM (CMCOM.AS).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biopharma Catalyst Cluster: Late-Stage Readouts and Regulatory Milestones
October 2026 brings a dense run of Phase 3 wins (ALOFT-IPF, RESTORE-3), new data presentations (Roche, Bayer, Lilly, Vertex, Galderma) and regulatory steps (FDA acceptance of Roche's vamikibart BLA, Scholar Rock's EMA resubmission). The next big catalyst is the ivonescimab FDA PDUFA date on 2026-11-14. Obesity combination studies (REDEFINE 4, TOGETHER-PsO) and the 2027 Maritime-1 completion point to more catalysts ahead. QAIAx's speculative AI-linked trial claims (the QIII pilot, targeted for 2027) are an unrelated micro-cap sideshow with weak evidence, and have little in common with the large-cap pipeline news.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,377 source documents archived
Query this data → isubstrate.com